Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,979
Closed -$1.38M 1930
2025
Q2
$1.29M Buy
9,979
+736
+8% +$89.1K 0.02% 498
2025
Q1
$1.1M Buy
+9,243
New +$1.15M 0.03% 433
2024
Q4
Sell
-2,374
Closed -$321K 2497
2024
Q3
$321K Sell
2,374
-12,037
-84% -$1.61M 0.01% 1532
2024
Q2
$1.95M Buy
14,411
+8,177
+131% +$1.11M 0.03% 423
2024
Q1
$806K Buy
+6,234
New +$753K 0.02% 767
2023
Q4
Sell
-4,819
Closed -$439K 2303
2023
Q3
$439K Buy
+4,819
New +$497K 0.01% 1011
2023
Q2
Sell
-160
Closed -$16.8K 2067
2023
Q1
$16.8K Sell
160
-2,102
-93% -$220K ﹤0.01% 1437
2022
Q4
$250K Buy
+2,262
New +$237K 0.01% 1028
2022
Q3
Sell
-11,566
Closed -$904K 1849
2022
Q2
$904K Buy
+11,566
New +$955K 0.02% 664
2021
Q3
Sell
-1,865
Closed -$224K 1654
2021
Q2
$224K Buy
+1,865
New +$213K 0.01% 1180

Other funds holding XYL

Centiva Capital's XYL Position: Q3 2025 in Review

Centiva Capital sold out of Xylem (XYL) in Q3 2025, closing a stake of 9,979 shares — an estimated $1.38M sold.

Centiva Capital first reported a position in XYL in Q2 2021 and held it in 10 quarters. The position peaked at $1.95M in Q2 2024. 1,085 funds tracked by Wall St. Rank hold XYL as of Q3 2025.

  • Centiva Capital reported no remaining Xylem position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 9,979 Xylem shares in Q3 2025, an estimated $1.38M.
  • Centiva Capital first reported a position in Xylem in Q2 2021 and held it in 10 quarters.
  • Centiva Capital's Xylem position peaked at $1.95M in Q2 2024.
  • 1,085 funds tracked by Wall St. Rank held Xylem as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.